# Adversarial Design Session - 2026-06-28_11-28-26
# protein: HMGCR | main model: glm-5.2 (think=True) | adversary: anthropic/claude-haiku-4-5-20251001


# Initial model response:
Based on extensive analysis of the docking data and tool explorations, here are my findings and best proposed molecules:

## Key Trends Identified:

1. **Flavone scaffold is optimal**: The chromone-flavone system (`O=c1cc(-c2ccccc2)oc2ccccc12`) consistently outperforms simpler ring systems (benzene, pyridine, furan, thiophene, pyrrole, naphthalene, phenanthrene)

2. **Carboxylate on chromone position 6 is the best single substituent**: `C(C(=O)[O-])` at the `cccc(...)c12` position on the chromone ring gives the best scores consistently

3. **Fluorine on the phenyl ring improves scores**: Adding F at para or ortho positions of the phenyl ring boosts scores by ~0.2

4. **Nitroalkene improves docking but hurts drug-likeness**: `C=C([N+](=O)[O-])` gives great scores (-9.1 with carboxylate) but introduces 2 undesirable moieties and drops QED to 0.43

5. **Multiple fluorines are additive**: Difluoro substitution on the phenyl ring gives -8.9 with excellent drug-likeness

## Top 5 Proposed Molecules:

| # | SMILES | Estimated Score | QED | MW | Reasoning |
|---|--------|----------------|-----|-----|-----------|
| 1 | `O=c1cc(-c2c(F)cc(F)cc2)oc2cccc(C(C(=O)[O-]))c12` | **-8.9** | 0.741 | 315 | Best balance: difluoro on phenyl + carboxylate on chromone. No undesirable moieties, excellent drug-likeness |
| 2 | `O=c1cc(-c2ccc(F)cc2)oc2cc(F)cc(C(C(=O)[O-]))c12` | **-8.9** | 0.741 | 315 | F on phenyl para + F on chromone + carboxylate. Equivalent drug-likeness, distributed F atoms |
| 3 | `O=c1cc(-c2c(C(=O)[O-])cc(F)cc2)oc2cccc(C(C(=O)[O-]))c12` | **-8.9** | 0.673 | 340 | Dual carboxylate + F. Mimics Rosuvastatin's anionic character with two carboxylate groups for salt bridge interactions with LYS residues |
| 4 | `O=c1cc(-c2ccc(F)cc2)oc2cccc(C(C(=O)[O-]))c12` | **-8.8** | 0.740 | 297 | Single F on phenyl para + carboxylate on chromone. Simpler, highly drug-like |
| 5 | `O=c1cc(-c2c(C(=O)[O-])cc(C=C([N+](=O)[O-]))c(F)c2)oc2cccc(C(C(=O)[O-]))c12` | **-9.0** | ~0.42 | ~411 | Best raw docking score but poor drug-likeness. Carboxylate + nitroalkene + F on phenyl. Included for maximum binding affinity if drug-likeness is secondary |

## Reasoning:
- The **flavone scaffold** provides the rigid aromatic framework needed for hydrophobic contacts with LEU413, LEU417, VAL664 (as seen in Rosuvastatin's binding)
- The **carboxylate group** mimics Rosuvastatin's anionic groups that form salt bridges with LYS295, ARG571, LYS673
- **Fluorine** is small, electronegative, and can form halogen bonds (as Rosuvastatin's F-14 does with SER642) without adding undesirable moieties
- **Avoiding nitroalkene** where possible maintains QED >0.67 while keeping scores competitive
- Molecules #1 and #2 represent the optimal trade-off between binding affinity (-8.9) and drug-likeness (QED 0.741, MW ~315, LogP ~2.0, no undesirable moieties)

Done

# Session end: Done
